Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888809467Aexternal-prioritypatent/GB8809467D0/en
Priority claimed from GB888809466Aexternal-prioritypatent/GB8809466D0/en
Priority claimed from GB888830174Aexternal-prioritypatent/GB8830174D0/en
Priority claimed from GB888830169Aexternal-prioritypatent/GB8830169D0/en
Priority claimed from PCT/DK1989/000079external-prioritypatent/WO1989010351A1/en
Application filed by Leo Pharm Prod LtdfiledCriticalLeo Pharm Prod Ltd
Priority to DK199002426ApriorityCriticalpatent/DK173457B1/da
Publication of DK242690ApublicationCriticalpatent/DK242690A/da
Publication of DK242690D0publicationCriticalpatent/DK242690D0/da
Application grantedgrantedCritical
Publication of DK173457B1publicationCriticalpatent/DK173457B1/da
Nuevos derivados de n-(23-vincristoil) y n-(5'-noranhidro-23-vinblastinoil) de acido 1-amino-metil-fosforico, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
Nya derivat av 1,8-dihydroxi-9-antron-serien, substituerade i 10-stellningen med en omettad grupp och anvendning derav inom human- eller veterinermedicinen och inom kosmetiken